The DOI matches its Crossref record.
Prevalence and predictors of interval colorectal cancers in Medicare beneficiaries
Open accessAbstract
BACKGROUND: After a colonoscopy that is negative for cancer, a subset of patients may be diagnosed with colorectal cancer, also termed interval cancer. The frequency and predictors have not been well studied in a population‐based US cohort. METHODS: The authors used the linked Surveillance, Epidemiology, and End Results (SEER)‐Medicare database to identify 57,839 patients aged ≥69 years who were diagnosed with colorectal cancer between 1994 and 2005 and who underwent colonoscopy within 6 months of cancer diagnosis. Colonoscopy performed between 6 and 36 months before cancer diagnosis was a proxy for interval cancer. RESULTS: By using the case definition, 7.2% of patients developed interval cancers. Factors that were associated with interval cancers included proximal tumor location (distal colon: multivariable odds ratio [OR], 0.42; 95% confidence interval [CI], 0.390‐0.46; rectum: OR, 0.47; 95% CI, 0.42‐0.53), increased comorbidity (OR, 1.89; 95% CI, 1.68 2.14 for ≥3 comorbidities), a previous diagnosis of diverticulosis (OR, 6.00; 95% CI, 5.57‐6.46), and prior polypectomy (OR, 1.74; 95% CI, 1.62‐1.87). Risk factors at the endoscopist level included a lower polypectomy rate (OR, 0.70; 95% CI, 0.63‐0.78 for the highest quartile), higher colonoscopy volume (OR, 1.27; 95% CI, 1.13‐1.43), and specialty other than gastroenterology (colorectal surgery: OR, 1.45; 95% CI, 1.16‐1.83; general surgery: OR, 1.42; 95% CI, 1.24‐1.62; internal medicine: OR, 1.38; 95% CI, 1.17‐1.63; family practice: OR, 1.16; 95% CI, 1.00‐1.35). CONCLUSIONS: A significant proportion of patients developed interval colorectal cancer, particularly in the proximal colon. Contributing factors likely included both procedural and biologic factors, emphasizing the importance of meticulous examination of the mucosa. Cancer 2012;118: 3044–52. © 2011 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Adenoma detection rate and risk of colorectal cancer and death
Corley, D. A., Jensen, C. D., Marks, A. R., Zhao, W. K., Lee, J. K., Doubeni, C. A., Zauber, A. G., de Boer, J., Fireman, B. H., Schottinger, J. E., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1309086 · Cited by 2,270
ACG Clinical Guidelines: Colorectal Cancer Screening 2021
Shaukat, A., Kahi, C. J., Burke, C. A., Rabeneck, L., Sauer, B. G., & Rex, D. K. (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001122 · Cited by 853
Hassan, C., Quintero, E., Dumonceau, J.-M., Regula, J., Brandão, C., Chaussade, S., Dekker, E., Dinis-Ribeiro, M., Ferlitsch, M., Gimeno-García, A., et al. (2013) · Endoscopy · doi:10.1055/s-0033-1344548 · Cited by 554
Colorectal Cancer Epidemiology: Recent Trends and Impact on Outcomes
Baidoun, F., Elshiwy, K., Elkeraie, Y., Merjaneh, Z., Khoudari, G., Sarmini, M. T., Gad, M., Al-Husseini, M., & Saad, A. (2021) · Current Drug Targets · doi:10.2174/1389450121999201117115717 · Cited by 523
Colorectal cancers soon after colonoscopy: a pooled multicohort analysis
Robertson, D. J., Lieberman, D. A., Winawer, S. J., Ahnen, D. J., Baron, J. A., Schatzkin, A., Cross, A. J., Zauber, A. G., Church, T. R., Lance, P., et al. (2014) · Gut · doi:10.1136/gutjnl-2012-303796 · Cited by 463
Metadata
- Authors
- Cooper, G. S., Xu, F., Barnholtz Sloan, J. S., Schluchter, M. D., & Koroukian, S. M.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2011-10-11
- Volume
- 118
- Issue
- 12
- Pages
- 3044-3052
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1800351647
- Cited by
- 235
- References
- 0
- FWCI
- 8.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence and predictors of interval colorectal cancers in Medicare beneficiaries. https://app.cochat.ai/papers/10.1002/cncr.26602
- The paper
- Cooper, G. S., Xu, F., Barnholtz Sloan, J. S., Schluchter, M. D., & Koroukian, S. M. (2012). Prevalence and predictors of interval colorectal cancers in Medicare beneficiaries. Cancer. https://doi.org/10.1002/cncr.26602
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.